Contact the Company at: | General Email: | ir@asiabroadbandinc.com | | --- | --- | | Token Support: | support@aabbgmine2token.com | | Company Websites: | www.asiabroadbandinc.com | | | www.aabbgmine2token.com | | | www.goldenbaboons.com | | Phone: | 702-744-4785 | Forward-Looking Statements are contained in this press release within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the Asia Broadband Inc.'s (the "Company") expected current beliefs about the C ...

Group 1 - FuelCell Energy, Inc. will release its second quarter 2025 results on June 6, 2025, before the stock market opens [1] - A conference call with investors will take place at 10:00 a.m. Eastern Time on the same day to discuss the results and provide a business update [1] - Participants can access the live call via webcast or telephone, with a replay available approximately two hours after the call [1][3] Group 2 - FuelCell Energy provides clean and reliable energy solutions that enable customers to access power quickly and manage emissions effectively [2] - The company's systems are efficient, scalable, and fuel-flexible, operating on natural gas, biofuels, or hydrogen, and provide steady baseload electricity [2] - With over 55 years of experience and nearly 200 plants deployed, FuelCell Energy assists customers in achieving their energy goals [2]

About DeFi Development Corp. BOCA RATON, FL, May 28, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the "Company" or "DeFi Dev Corp."), the first public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced its adoption of liquid staking token ("LST") technology. As part of this initiative, DeFi Dev Corp. will invest part of its SOL treasury in dfdvSOL, an LST representing stake delegated to DeFi Dev Corp. validators and built with protocol infras ...

LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q25") and full fiscal year ("FY25") ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Full FY25 compared to full FY24: We operate our business in four divisions: Sterilization and Disinfection Control ("SDC"), ...

Hudbay did not have a NCIB in place during the 12-month period preceding the date hereof, and accordingly, no Shares were repurchased or cancelled during that period. TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. ("Hudbay" or the "company") (TSX, NYSE: HBM), announced today that the Toronto Stock Exchange (the "TSX") has approved its notice of intention to commence a normal course issuer bid ("NCIB") for its common shares ("Shares"). The NCIB will be made in accordance with the requirements ...

All resolutions approved at the 2025 STMicroelectronics' Annual General Meeting of Shareholders Amsterdam, May 28, 2025 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announced the results related to the voting items of its 2025 Annual General Meeting of Shareholders (the "2025 AGM"), which was held today in Amsterdam, the Netherlands. All the resolutions were approved by the Shareholders: The complete agenda and all relevan ...

Core Insights - Cocrystal Pharma, Inc. will participate in a fireside chat at the Noble Capital Markets' 2025 Emerging Growth Virtual Equity Conference on June 5, 2025 [1] - The company is a clinical-stage biotechnology firm focused on developing antiviral therapeutics targeting various viruses [3] Company Overview - Cocrystal Pharma specializes in discovering and developing novel antiviral drugs aimed at noroviruses, influenza viruses, coronaviruses (including SARS-CoV-2), and hepatitis C viruses [3] - The company utilizes unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral therapeutics [3] Event Details - Registered investors can request one-on-one meetings with Cocrystal management through the conference registration platform [2] - A video webcast of the presentation will be available approximately 48 hours after the event and archived for 90 days on the company's website and Channelchek [2]

Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" OR "Vaxart") today answers additional frequently asked stockholder questions it has received from retail investors in advance of the Company's Annual Meeting of Stockholders scheduled to take place on Monday, June 2, 2025. "We appreciate the continued interest from our passionate and loyal stock ...

Target enrollment exceeded with 62 participants enrolled, including approximately 15 percent from U.S. sites Topline data is anticipated in December of 2025 REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced that enrollment is complete in the sunRIZE study, a global, Phase 3 multicenter, double-blind, randomized, placebo-controlle ...

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia's mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com. Forward Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 2 ...